Tyverb News
Most Popular Tyverb Story
Bayer wins, Glaxo loses at NICE
The U.K.'s National Institute for Health and Clinical Excellence gives--and it takes away. The drugs gatekeeper has recommended Bayer's Xarelto anti-clotting treatment for the National Health Service Read more...
Latest Headlines
- October 14, 2010
- October 21, 2009
- July 9, 2009
- March 5, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
